Avandia Lawsuits Filed in Illinois For 186 People

Two new Avandia lawsuits were filed this week in Illinois state court, encompassing 186 plaintiffs from across the United States, who claim that a variety of illnesses and complications, including several deaths, were caused by the type 2 diabetes drug.

According to The Madison Record, the complaints were filed on May 15, 2009 in St. Clair County Circuit Court against the manufacturer of Avandia, GlaxoSmithKline PLC, alleging that the drug company failed to provide adequate warnings to consumers and health professionals about potentially life-threatening Avandia side effects.

At least nineteen of the plaintiffs included on the complaints indicate that a death from Avandia was suffered by one of their relatives.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

In 2007, Avandia (rosiglitazone) was associated with an increased risk of congestive heart failure, heart attacks and death, leading to a “black box” warning.

Since that time, consumer advocacy groups have called for an Avandia recall to be issued due to mounting evidence of potentially life-threatening side effects, and many experts have questioned the rationale for continued use of Avandia.

In addition to the increased risk of heart problems, side effects of Avandia have been associated with a potential increased risk of liver failure, bone fractures and a form of vision loss known as macular edema.

The 186 plaintiffs who filed their Avandia lawsuit in St. Claire County, join thousands of other people who have filed cases in state and federal courts throughout the United States.

All federal lawsuits over Avandia are consolidated in an MDL, or Multidistrict Litigation, that is centralized in the Eastern District of Pennsylvania before U.S. District Judge Cynthia Rufe. The first Avandia suit is scheduled for trial to begin early next summer.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.